Back to search

Article

Molecular Biomarkers in Lymphangioleiomyomatosis (LAM)

2024-05-17

Abstract excerpt

Lymphangioleiomyomatosis (LAM) is a cystic pulmonary disorder that has been known to primarily affect women of childbearing age. The disorder can develop with mutations in the tuberous sclerosis (TSC) genes TSC1 & TSC2 but may arise by other irregular cases in the lack of these mutations. LAM can manifest in a wide variety of ways and generally compounded in symptoms of other lung disorders such as bronchitis,...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
29f27807-1d4f-5540-9042-84b7d7a05227
DOI
10.20944/preprints202405.1161.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Molecular Biomarkers in Lymphangioleiomyomatosis (LAM)DOI 10.20944/preprints202405.1161.v1
Select a neighboring publication to make it the new centre.